#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#
preLekára.sk / Journals / Diabetes and obesity / 2024 - 47

MUDr. Adriana Philippiová

Czech version

Published in: Diab Obez 2024; 24(47): 86-87
Category: Personalities

Labels
Diabetology Obesitology
Editorial
Early use of SGLT2-inhibitors i in the treatment of type 2 diabetes mellitus
Integration of glycemic compensation markers, including glycemic variability in patients with diabetes mellitus
Metformin in the treatment of type 2 diabetes mellitus and its current position
Inklisiran and its role in lipid-lowering therapy
Slovak Diabetes Society recommendations for diabetes education
Type 2 diabetes mellitus and obesity – dangerous companions
Coexistence of SGLT2 inhibitors and GLP-1 receptor agonists in the treatment of a patient with type 2 diabetes mellitus
Current position of GLP-1 receptor agonists in type 2 diabetes mellitus treatment
Long-term sustainability of metabolic compensation in telemedicine use – results of 18 months follow-up
Diabetic distress from clinical diabetology view
6th National SDS Symposium: Where are we moving with technology in diabetology in Slovakia?
Pilot project for early detection of hyperglycemia, prediabetes and/or diabetes mellitus in insured persons of VšZP, a.s., and throughout Slovakia in specialist outpatient clinics of diabetologists in diabetes-naïve patients: report
Advanced Technologies & Treatments for Diabetes 2024, Florencia – sumár z kongresu
MUDr. Lívia Tomášová
Diabetics from all over Slovakia on reconditioning stays
Article was published in

Diabetes and obesity

Issue 47
2024 Issue 47
Popular this week
Most read in this issue
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#